Mediators of Inflammation 2006-01-01

The evaluation of the role of beta-hydroxy fatty acids on chronic inflammation and insulin resistance.

A S Soydan, H S Dokmetas, M Cetin, A Koyuncu, E Kaptanoglu, H Elden

Index: Mediators Inflamm. 2006 , 64980, (2006)

Full Text: HTML

Abstract

Beta-hydroxy fatty acids are a major component of lipid A moiety of lipopolysaccharide. We aimed to investigate the role of free beta-hydroxy fatty acids on inflammation, as well as to evaluate their effects on cytokine release from human blood cells, and whether they exist in plasma of patients with chronic inflammatory diseases with/without insulin resistance. Peripheral venous blood was incubated with beta-hydroxy lauric and beta-hydroxy myristic acids (each 100 ng, 1 microg, 10 microg/mL) up to 24 hours. Cytokines were measured from culture media and plasma. Free fatty acids and biochemical parameters were also measured from patients' plasma. Only beta-hydroxy lauric acid significantly stimulated interleukin-6 production at 10 microg/mL compared to control (533.9 +/- 218.1 versus 438.3 +/- 219.6 pg/mL, P < .05). However, free beta-hydroxy lauric and myristic acids were not found in patients' plasma. Therefore, free beta-hydroxy lauric and myristic acids do not seem to have a role on sterile inflammation in chronic inflammatory diseases associated with insulin resistance.


Related Compounds

  • 3-Hydroxydodecanoi...
  • DL-B-HYDROXYM...

Related Articles:

Analysis of polyhydroxyalkanoate (PHA) synthase gene and PHA-producing bacteria in activated sludge that produces PHA containing 3-hydroxydodecanoate.

2013-09-01

[FEMS Microbiol. Lett. 346(1) , 56-64, (2013)]

Determination of monomeric composition in polyhydroxyalkanoates by liquid chromatography coupled with on-line mass spectrometry and off-line nuclear magnetic resonance.

2016-01-01

[Talanta 146 , 107-13, (2015)]

Mitochondrial bioenergetics deregulation caused by long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies in rat brain: a possible role of mPTP opening as a pathomechanism in these disorders?

2014-09-01

[Biochim. Biophys. Acta 1842(9) , 1658-67, (2014)]

Analysis of 3-hydroxydodecanedioic acid for studies of fatty acid metabolic disorders: preparation of stable isotope standards.

2002-01-01

[J. Clin. Lab Anal. 16(2) , 115-20, (2002)]

Production of polyhydroxyalkanoates with high 3-hydroxydodecanoate monomer content by fadB and fadA knockout mutant of Pseudomonas putida KT2442.

2007-08-01

[Biomacromolecules 8 , 2504-2511, (2007)]

More Articles...